BridgeMD
Tests treatment safety and results for Insomnia
Official title Examining the Effectiveness of Two Behavioral Interventions for Sleep Problems in Infants
ClinicalTrials.gov ID: NCT05726890
What this study is testing
- What it's testing
- Behavioral insomnia of childhood affects 15-30% of infants. Behavioral interventions, based on limiting parent-child bedtime and nighttime interactions, are effective in significantly improving infant sleep problems.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 9 to 18
You may be able to join if
- Early-childhood insomnia according to DSM-5 criteria
- The parents wish to sleep independently from the child and would like the infant to need as little help as possible to fall asleep or stay asleep
- Two-parent, Hebrew-speaking families.
- Infants born at term (gestational age \> 36 weeks)
You likely can't join if
- Infants and parents with significant physiological sleep problems (e.g., sleep apnea)
- Infants and parents with any chronic health problems (based on self-report).
The study team makes the final eligibility decision.
Where it's taking place
- Beersheba, Israel
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 9 months to 18 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beersheba, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.